This recipe comes from a popular French method of cooking called en papillote...
Patients with APS are diagnosed based on the co-occurrence of several diseases, such as Addison’s disease, thyroiditis, and Graves’ disease...
According to a new report published in the Lancet, taking a low dose of GlaxoSmithKline's diabetes drug Avandia (rosiglitazone) combined with metformin was highly effective in prevention of type 2 diabetes in patients with impaired glucose tolerance, with little effect on the clinically relevant adverse events of these two drugs.
The study included 207 patients with impaired glucose...
Novo Nordisk announced that it has received approval for the price of Victoza, a once-daily human GLP-1 analogue for the treatment of type 2 diabetes, from Japan’s Central Social Insurance Medical Council (Chuikyo), the advisory committee to the Minister of Health, Labour and Welfare. The price approval allows Novo Nordisk to commercially launch in Japan shortly after Victoza is officially posted on Japan’s National Health Insurance price list on June 11th...
Sitting in a hospital for about five hours every day for 14 days, I developed a new perspective on this whole journey. In just two short months, my…
GlaxoSmithKline Plc has settled thousands more lawsuits brought by patients alleging its Avandia diabetes drug caused heart attacks, in a move that may defuse potentially massive claims over the medicine.
According to a Reuters report, a spokeswoman for Glaxo said that consolidated cases which had been due to come to court...
One day Maiya came up to me with tears in her eyes and told me that her bag made her sad and she was embarrassed that she had to carry her "ugly" diabetes bag...
Crystal Bowersox, a type 1 diabetic and this year’s American Idol runner-up, recently said in an interview that there were times when she had to…
It has been a week and a half since I started this experiment and I’ve run seven times. Each run has been different, and thankfully, my heart rate has…
Novo Nordisk has decided to stop sales of its insulin product in Greece following a government decree ordering a 25% price cut in all medicines, according to a BBC report. The company, which claims it is owed 32 million dollars by the Greek state, said that such a price cut would force its business in Greece to run at a loss. The company was also concerned that the compulsory 25% reduction would have a knock-on effect since other countries use Greece as a key reference point for setting drug prices...